De Novo Mutations in Ataxin-2 Gene and ALS Risk

Citations of this article
Mendeley users who have this article in their library.


Pathogenic CAG repeat expansion in the ataxin-2 gene (ATXN2) is the genetic cause of spinocerebellar ataxia type 2 (SCA2). Recently, it has been associated with Parkinsonism and increased genetic risk for amyotrophic lateral sclerosis (ALS). Here we report the association of de novo mutations in ATXN2 with autosomal dominant ALS. These findings support our previous conjectures based on population studies on the role of large normal ATXN2 alleles as the source for new mutations being involved in neurodegenerative pathologies associated with CAG expansions. The de novo mutations expanded from ALS/SCA2 non-risk alleles as proven by meta-analysis method. The ALS risk was associated with SCA2 alleles as well as with intermediate CAG lengths in the ATXN2. Higher risk for ALS was associated with pathogenic CAG repeat as revealed by meta-analysis. © 2013 Laffita-Mesa et al.




Laffita-Mesa, J. M., Rodríguez Pupo, J. M., Moreno Sera, R., Vázquez Mojena, Y., Kourí, V., Laguna-Salvia, L., … Pérez, L. V. (2013). De Novo Mutations in Ataxin-2 Gene and ALS Risk. PLoS ONE, 8(8).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free